Skip to main content
. Author manuscript; available in PMC: 2010 Dec 21.
Published in final edited form as: Transplant Proc. 1991 Dec;23(6):3010–3015.

Table 1. Pretransplantation Clinical Profile of the Patients in the Study and Control Group.

FK 506 CyA
Number 59 50
Median age 2.7 years (0.2 to 16.5) 1.8 years (0.3 to 15.2)
Male/female 31/28 22/28
Cholestatic liver disease 38 36
A-1-A 3 3
Neonatal hepatitis 5 2
Cystic fibrosis 3 2
Fulminant hepatitis 2 2
Hepatoblastoma 2 2
All others 6 2
Previous Kasai 30 28
PRA > 10% 4 4
Gross × (+)
 Strongly 1 4
 Weakly 10 4